Scientists are hoping to prove that type 1 diabetes can be reversed with the help of a generic drug. The five-year long, phase II clinical trial, which received approval from the U.S. Food and Drug Administration, was recently announced. Denise Faustman, associate professor of medicine at Massachusetts General Hospital, is principal investigator of the study.
News & Research
